Am J Psychiatry 156:662, April 1999
© 1999 American Psychiatric Association
Chronic Psychotic Illness From Methamphetamine
ALAN BUFFENSTEIN, M.D.,
JOHN HEASTER, M.D., and
PETER KO, M.D.
Honolulu, Hawaii
To the Editor: In the past decade, methamphetamine abuse has been on the rise throughout the United States (1, 2). Although methamphetamine is generally taken orally or intravenously, crystal methamphetamine or "ice" is smoked. This manner of admission is highly addictive. It is odorless, difficult to detect, and less expensive and longer lasting than crack. Vaporized crystal methamphetamine, when inhaled, is rapidly absorbed through lung capillaries and has pharmacokinetics similar to intravenous amphetamines. With continued abuse, crystal methamphetamine usually leads to paranoid, often violent, psychotic states accompanied by auditory and tactile hallucinations. Many, but not all, patients improve with abstinence and symptomatic treatment with low-dose neuroleptics. Brain damage to dopamine and 5-hydroxytryptamine receptors from the vasoconstriction and neurotoxicity of methamphetamine has been documented in animals (3). Our experience in Hawaii has provided some clinical evidence to support this.
While binding sites and cerebral perfusion deficits resulting from cocaine and crack abuse have been mapped out with single photon emission computed tomography (SPECT), identifying focal and long-term perfusion deficits in frontal and temporal lobes (4–6), no known study of cerebral perfusion in crystal methamphetamine abusers has been published to date. To assess brain perfusion deficits in crystal methamphetamine abusers, we used SPECT to scan 21 crystal methamphetamine abusers with psychotic symptoms. Scans were read by qualified neuroradiologists who were blind to the diagnoses. Length of crystal methamphetamine abuse ranged from 3 months to 10 years. No patients' charts showed a history of psychotic diagnosis or symptoms before the use of crystal methamphetamine. Sixteen of the 21 (76%) crystal methamphetamine abusers had focal perfusion deficits distributed in the frontal, parietal, and temporal lobes. A similar cerebral perfusion profile has been described for those who exhibit violent or aggressive behavior (7). Although our study group size was small, dose and length of exposure appear to be related to the extent of the perfusion deficits. In a few additional crystal methamphetamine abusers with psychotic symptoms, multiple SPECT scans have been done to document deficits over time—even years after crystal methamphetamine has left their bodies.
The "ice age" in Hawaii has shown methamphetamine abuse to be both debilitating and dangerous. Our preliminary findings suggest that crystal methamphetamine abuse leads to short-term and potentially long-term functional abnormalities linked to violence. Further research is needed. Clinical data and SPECT scans on crystal methamphetamine abusers are now being reviewed.
REFERENCES
-
Office of National Drug Control Policy. Methamphetamine: Facts and Figures. Rockville, Md, Office of National Drug Control Policy, 1997
-
Baberg HT, Nelesen RA, Dimsdale JE: Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry 1996; 153:789–793[Abstract/Free Full Text]
-
Seiden LS: Neurotoxicity of methamphetamine: mechanisms of action and issues related to aging. National Institute on Drug Abuse Research Monograph Series 1991; 115:72–83
-
Holman BL, Carvalho PA, Mendelson J, Teoh SK, Nardin R, Hallgring E, Hebben N, Johnson KA: Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and SPECT. J Nucl Med 1991; 32:1206–1210[Abstract/Free Full Text]
-
Weber DA, Fanceschi D, Ivanovic M, Atkins HL, Cabahug C, Wong CTC, Susskind H: SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization. J Nucl Med 1993; 34:899–907[Abstract/Free Full Text]
-
Volkow HD, Hitzemann R, Wang GJ, Fowler JS: Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11:184–190[Medline]
-
Amen DG, Stubblefield M, Carmichael B, Thisted R: Brain SPECT findings and aggressiveness. Ann Clin Psychiatry 1996; 8:129–137[Medline]
This article has been cited by other articles:
|
|
|
|
 
N. R. Pinninti, R. Mago, and Adityanjee
Tardive Dystonia-Associated Prescription of Aripiprazole
J Neuropsychiatry Clin Neurosci,
August 1, 2006;
18(3):
426 - 427.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. BARGLOW
Misunderstanding Freud
Am J Psychiatry,
April 1, 2005;
162(4):
826 - 827.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Kalechstein, T. F. Newton, and M. Green
Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of Abstinence
J Neuropsychiatry Clin Neurosci,
May 1, 2003;
15(2):
215 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori
Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET
Am J Psychiatry,
August 1, 2001;
158(8):
1206 - 1214.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
